Keynote review: In vitro safety pharmacology profiling: an essential tool for successful drug development
Top Cited Papers
- 1 November 2005
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 10 (21), 1421-1433
- https://doi.org/10.1016/s1359-6446(05)03632-9
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Phenytoin-loading: pharmacokinetic comparison between an intravenous bolus injection and a diluted standard solutionActa Neurologica Scandinavica, 2009
- Ten lessons to be learned from the withdrawal of Vioxx® (rofecoxib)European Journal of Epidemiology, 2005
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 2004
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Predicting undesirable drug interactions with promiscuous proteins in silicoDrug Discovery Today, 2004
- Emerging safety issues regarding long-term usage of H1-receptor antagonistsExpert Opinion on Drug Safety, 2002
- Does potency predict clinical efficacy? Illustration through an antihistamine modelAnnals of Allergy, Asthma & Immunology, 2002
- Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizoleFEBS Letters, 1996
- Neighborhood Behavior: A Useful Concept for Validation of “Molecular Diversity” DescriptorsJournal of Medicinal Chemistry, 1996
- Modulation of feeding by hypothalamic paraventricular nucleus α1- and α2-adrenergic receptorsLife Sciences, 1993